Delivery Order SPE2DR25D3201-SPE2DR26FT4YB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,662.25 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities. The contract, awarded on July 29, 2025, with a completion date of July 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500-milligram mycophenolate tablets (500 count) on December 16, 2025, with a ceiling value of $7,263.05 and ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency has awarded a delivery order valued at $2,990.28 to AmerisourceBergen Drug Corp for 100 tablets of Mycophenolate 500 mg, with an ultimate completion date of April 23, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on April 22, 2025. The pharmaceutical product will be delivered to Conshohocken, PA, where AmerisourceBergen Drug Corp maintains its corporate office and primary operations. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,520.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S to Conshohocken, PA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up...
- The Defense Logistics Agency awarded a delivery order valued at $1,873.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 14, 2025, with a completion date of November 17, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide 160 ml bottles of Mycophenolate 200 mg/ml suspension. The $3,561.92 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order. No set-aside designation was used. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $14,609.25 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, on December 10, 2025. This firm fixed price contract, which also serves as the ultimate completion date, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order was competitively awarded with no set-aside designation and will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $16,069.49 from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, is scheduled for completion by December 2, 2025, and will be performed at the awardee's Conshohocken facility. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $142,578.56 to AmerisourceBergen Drug Corp on December 22, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents pharmaceutical products and medical supplies to be delivered to the Conshohocken, Pennsylvania location. The contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4YBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Mycophenolate 200 mg/ml suspension in 160 ml quantities, with a ceiling value of $1,288.62. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of December 29, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies through competitive awards, ranging from small-value transactions to substantial orders. The DLA Pharmaceutical Prime Vendor program, under which this delivery order falls, provides critical medical commodities including specialty medications, brand-name and generic drugs, and related supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/25/25 |